Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

In patients with severe COVID‐19, acute respiratory distress syndrome (ARDS), multiple
organ dysfunction syndrome (MODS), and even mortality can result from cytokine storm …

It has been reported that corticosteroid therapy was effective in the management of severe
acute respiratory syndrome (SARS) and the Middle East Respiratory Syndrome (MERS) …

Background It is important to predict which patients infected by SARS-CoV-2 are at higher
risk of life-threatening COVID-19. Several studies suggest that neutralizing auto-antibodies …

Objectives Efficacy and safety of corticosteroids in patients with 2019-nCoV (novel
coronavirus 2019) infection still are debated. Because large randomized clinical trials …

Background The WHO ordinal severity scale has been used to predict mortality and guide
trials in COVID-19. However, it has its limitations. Objective The present study aims to …

Пандемия коронавирусной болезни 2019 (coronavirus disease, COVID-19),
этиологически связанной с вирусом SARS-CoV-2 (severe acute respiratory syndrome …

Among patients suffering from coronavirus disease 2019 (COVID-19) syndrome, one of the
worst possible scenarios is represented by the critical lung damage caused by the severe …

Introduction The results of studies of tocilizumab (TCZ) in COVID‐19 are contradictory. Our
study aims to update medical evidence from controlled observational studies and …

Objectives In severe COVID-19 pneumonia, the appropriate timing and dosing of
corticosteroids (CS) is not known. Patient subgroups for which CS could be more beneficial …